Table 4.
Factors associated with rtPA in the male dyslipidemic stroke population.
| B Value | Wald | Odds Ratio | 95% C.I. Lower |
For OR Upper |
P Value | |
|---|---|---|---|---|---|---|
| Age | 0.005 | 0.142 | 1.005 | 0.981 | 1.029 | 0.707 |
| BMI | -0.010 | 0.175 | 0.991 | 0.947 | 1.036 | 0.676 |
| NIH Stroke Scale | -0.130 | 8.409 | 0.879 | 0.805 | 0.959 | 0.004* |
| Risk of Mortality GWTG | 0.062 | 1.228 | 1.064 | 0.954 | 1.186 | 0.268 |
| Race | 0.237 | 0.645 | 1.268 | 0.711 | 2.261 | 0.422 |
| Atrial Fibrillation | 0.719 | 4.537 | 2.053 | 1.059 | 3.978 | 0.033* |
| Coronary Artery Disease | 0.015 | 0.003 | 1.015 | 0.613 | 1.682 | 0.953 |
| Carotid Artery Stenosis | 0.875 | 4.426 | 2.400 | 1.062 | 5.424 | 0.035* |
| Diabetes | -0.035 | 0.007 | 0.965 | 0.420 | 2.217 | 0.934 |
| Congestive Heart Failure | 0.431 | 1.297 | 1.539 | 0.733 | 3.230 | 0.255 |
| Hypertension | -0.339 | 0.528 | 0.712 | 0.285 | 1.778 | 0.467 |
| Previous Stroke | 0.579 | 4.798 | 1.785 | 1.063 | 2.998 | 0.028* |
| Previous TIA | -0.256 | 0.576 | 0.774 | 0.400 | 1.500 | 0.448 |
| Peripheral Vascular Disease | 0.377 | 0.704 | 1.457 | 0.605 | 3.512 | 0.401 |
| History of Smoking | -0.426 | 1.986 | 0.653 | 0.361 | 1.181 | 0.159 |
| Antiplatelet medication | -0.628 | 4.589 | 0.534 | 0.301 | 0.948 | 0.032* |
| Antihypertensive medication | -0.321 | 0.679 | 0.725 | 0.338 | 1.557 | 0.410 |
| Cholesterol Reducer | -0.226 | 0.562 | 0.798 | 0.442 | 1.441 | 0.454 |
| Antidiabetic medication | 0.235 | 0.265 | 1.265 | 0.517 | 3.092 | 0.607 |
Positive B values (Adj, OR > 1) denote variables more associated with rtPA exclusion while negative B values (Adj. OR < 1) denote variables more associated with rtPA inclusion. Multicollinearity and interactions among independent variables were checked. Hosmer-Lemeshow test (P = 0.356), Classification table (overall correctly classified percentage = 66.7%), and area under the ROC curve (AUC = 0.726) were applied to check the model fitness